About Syntekabio
Syntekabio is a company based in Sunnyvale (United States) founded in 2009. Syntekabio has raised $11.12 million across 2 funding rounds from investors including Smile Gate Investment, Korea Development Bank Europe and Altos Ventures Management. The company has 61 employees as of December 31, 2024. Syntekabio operates in a competitive market with competitors including NantHealth, BioAge Labs, Perthera, Genedata and Ontoforce, among others.
- Headquarter Sunnyvale, United States
- Employees 61 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Syntekabio, Inc.
-
Annual Revenue
$81.96 K (USD)-2.04as on Dec 31, 2024
-
Net Profit
-$4.89 M (USD)36.71as on Dec 31, 2024
-
EBITDA
-$8.35 M (USD)-14.29as on Dec 31, 2024
-
Total Equity Funding
$11.12 M (USD)
in 2 rounds
-
Latest Funding Round
$7.39 M (USD), Post-IPO
Apr 03, 2024
-
Investors
Smile Gate Investment
& 3 more
-
Employee Count
61
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Syntekabio
Syntekabio is a publicly listed company on the KRX with ticker symbol 226330 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Syntekabio
Syntekabio has successfully raised a total of $11.12M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7.39 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Syntekabio
Syntekabio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Smile Gate Investment, Korea Development Bank Europe and Altos Ventures Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on buyouts
|
Locked | Locked | Locked | |
|
Early-stage companies are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Operates as a commercial bank providing deposits, loans, and payment services to customers.
|
Locked | Locked | Locked |
Investor details for Syntekabio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Syntekabio
Investment portfolio details for Syntekabio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Syntekabio
Detailed financials for Syntekabio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Syntekabio Comparisons
Peer comparison for Syntekabio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Syntekabio
Syntekabio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NantHealth, BioAge Labs, Perthera, Genedata and Ontoforce, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for cancer treatment identification.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Molecular cancer profiling is conducted via genomics and proteomics.
|
|
| Locked | Locked | Locked |
Software solutions are developed for drug discovery and life sciences.
|
|
| Locked | Locked | Locked |
Semantic search platform is provided for pharmaceutical and biotech research.
|
|
| Locked | Locked | Locked |
AI-powered real-world data platform is provided for clinical development.
|
Detailed competitors of Syntekabio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Syntekabio
Complete news archive for Syntekabio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syntekabio
Syntekabio was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Syntekabio is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Syntekabio is a funded company, having raised a total of $11.12M across 2 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Syntekabio is 61.
Annual revenue of Syntekabio is $81.96K as on Dec 31, 2024.
Syntekabio provides life science-specific software and services. It offers General Purpose BioMap Service (GPBS) which is a suite of dynamic workflows. They have developed SQL and BIO DBS, a biomedical database integration tool. BioMaps cover biomedical component maps including Gene, PPI, Pathway-Map, Compound-Map, SNP-Map, and Map 2 Map. The service includes value-added analytics providing multiple mapping such as M2BM (Map to Blockbuster DB Maps), M2AM (Map to Any kinds of diseases, drugs, or functional categories MAPs), M2PM(Map to Public Medline DB Map), IQC (Inter-Query Correlation), etc.
Syntekabio's top competitors include NantHealth, BioAge Labs and Genedata.
Yes, Syntekabio is publicly traded on KRX under the ticker symbol 226330.
Syntekabio has 4 investors. Key investors include Smile Gate Investment, Korea Development Bank Europe, Altos Ventures Management, and Yozma Group Korea.
The ticker symbol of Syntekabio is 226330 on KRX.